AMS Grew Revenue 14% and Lost More Money Doing It — and the Language of the Call Changed Hands
Direct patient services keeps compounding, but the keyword deck has flipped from 'operational execution' to lenders, allowances and legal fees, with a Fifth Third forbearance clock running to June 2027 and the stock down 28% in ninety days.
AMS · Earnings Call · 2026-11-12
The Revenue Line Works. The Earnings Line Doesn't.
American Shared Hospital Services won the argument it set out to win years ago: the shift into direct patient services business is real and it is compounding. Third-quarter revenue rose 6.3% to $7.6 million and nine-month revenue 13.7% to $23.1 million, with direct patient services up 27% to $13.5 million over nine months and Medical Equipment Leasing segment revenue holding at roughly $9.6 million — a flat annuity that now funds the growth story rather than being it. Total Gamma Knife facilities in Peru and Ecuador procedures rose about 11% in both periods, helped by the Esprit upgrade. Except the earnings line went the other way. Gross margin fell to 19.9% from 22.1%, and the quarterly net loss widened to $620,000, or $0.09 a share, from $17,000 a year earlier. Over nine months the loss nearly doubled to $1.7 million from $922,000. EBITDA slipped to $1.4 million from $1.9 million. The proximate cause is not clinical: administrative expenses increased to $5.8 million from $5.1 million, and management pinned the delta on legal, banking and consulting work tied to the credit agreement. Gross margin in the last filed quarter was 17.0%, down 25 points over three years and 65% below the 2017 peak of 49.5%. That is the price of the pivot, and it was telegraphed. What was not telegraphed is how long the pivot's overhead would run. Total revenue of $8 million in the last filed quarter was up 19% year over year.The Language Changed Hands
This is where the quarter gets interesting. Look at what AMS used to talk about and no longer does. In the third quarter of 2025 the deck carried capital structure at a prominent rank and operational execution as a live theme; in the same era there was cash generation, installed base and patient throughput. Those words are aspirational. They describe a company managing for growth. This quarter's top keywords are diagnostic in a different way: increased allowance for credit losses associated with the Rhode Island facilities, the credit agreement with Fifth Third, and financing arrangements requiring "continued attention and execution against specified milestones." "Operational execution" itself now appears on the company's own decliner list — the sharpest conceptual drop of the quarter. When a management team stops leading with execution and starts leading with forbearance, the market hears it. It is the second consecutive quarter of a Rhode Island receivable problem. In August, private investor Anthony Marchese pressed management on a roughly $900,000 accounts receivable charge and complained that “every quarter, there is something. If it is not a center that was closed, it was maintenance, if not maintenance now, it is, you know, accounts receivable.” — Anthony Marchese · 2026-08-13 The answer then was insurance carriers. This quarter the same bucket got topped up again. Receivables ran at 98.7% of revenue in the last filed quarter, down 36.7 points year over year but still near a decade of one-times-revenue readings.That is Executive Chairman Ray Stachowiak on Rhode Island, and it is the most honest sentence in the deck. Revenue there is up; procedure volumes are down; the revenue cycle is not converted.We're in a process of maybe taking 2 steps forward and 1 step backward sometimes it seems.